MPM BioImpact’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-351,350
| Closed | -$9.43M | – | 41 |
|
2022
Q1 | $9.43M | Buy |
351,350
+80,000
| +29% | +$2.15M | 2.53% | 9 |
|
2021
Q4 | $12.9M | Hold |
271,350
| – | – | 2.36% | 10 |
|
2021
Q3 | $18M | Buy |
271,350
+2,164
| +0.8% | +$144K | 2.8% | 12 |
|
2021
Q2 | $21M | Hold |
269,186
| – | – | 3.45% | 9 |
|
2021
Q1 | $25.5M | Sell |
269,186
-39,500
| -13% | -$3.74M | 3.2% | 8 |
|
2020
Q4 | $37.6M | Hold |
308,686
| – | – | 6.61% | 6 |
|
2020
Q3 | $27M | Hold |
308,686
| – | – | 6.5% | 7 |
|
2020
Q2 | $19.9M | Hold |
308,686
| – | – | 5.3% | 8 |
|
2020
Q1 | $13.8M | Buy |
+308,686
| New | +$13.8M | 8.42% | 5 |
|